EBV-positive lymphoproliferative disease with medullar, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia with two relapses and rituximab resistance No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback